Revolade

Revolade Description

Manufacturer:

Novartis Oncology

Distributor:

DKSH
Full Prescribing Info
Description
Each film-coated tablet contains eltrombopag olamine equivalent to either: 25 mg or 50 mg of eltrombopag as eltrombopag free acid.
Excipients/Inactive Ingredients: Tablet core: Microcrystalline cellulose, Mannitol, Sodium starch glycolate, Magnesium stearate, Povidone.
Tablet coating: See Table 1.

Click on icon to see table/diagram/image
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in